Skip to content

Application of Noninvasive External Cardiac Pacing in Emergency PCI for AIMI Patients

Application of Noninvasive External Cardiac Pacing in Emergency PCI for AIMI Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119790
Enrollment
Unknown
Registered
2026-03-03
Start date
2024-05-15
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute inferior myocardial infarction(AIMI)

Interventions

Control group:Intravenous temporary pacemaker implantation
Experimental group:The patient underwent emergency PCI under the protection of non-invasive external cardiac pacing.

Sponsors

Affiliated Hospital of Yanbian University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Age >=18 years, no gender restrictions; (2) Meets diagnostic criteria for acute inferior myocardial infarction (AIMI) (refer to the 2019 Guidelines for Diagnosis and Treatment of Acute ST-Elevation Myocardial Infarction): Persistent chest pain lasting >10–20 minutes, unrelieved by rest or sublingual nitroglycerin; ECG showing ST-segment elevation >0.1 mV in leads II, III, and aVF; elevated serum cardiac injury markers (e.g., troponin, creatine kinase isoenzymes); (3) Scheduled for emergency PCI within 12 hours of symptom onset; (4) The patient or their legal representative voluntarily signs a written informed consent form, agreeing to complete the entire study and follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients with combined cerebral hemorrhage; 2. Patients with malignant tumors; 3. Patients with severe liver or kidney dysfunction; 4. Patients with coagulation disorders; 5. Patients with severe valvular heart disease; 6. CABG patients, etc.

Design outcomes

Primary

MeasureTime frame
Pacing efficacy;Postoperative LVEF and LVEF recovery rate at 3 months postoperatively;Operating time;

Secondary

MeasureTime frame
Intraoperative drug use;Reperfusion injury and occurrence of malignant arrhythmias;Perioperative complications;Occurrence and improvement of high-grade atrioventricular block;Length of stay;The occurrence of cardiovascular events during the 6-month follow-up period after surgery;Incidence rate of malignant arrhythmia;Need for defibrillation;LVEF value;

Countries

China

Contacts

Public ContactYuzi Li

Yanbian University Affiliated Hospital

liyuzi9258@163.com+86 155 2677 0374

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026